First domestically created oral COVID-19 drug

Japan // 22 November, 2022

Shionogi & Co Ltd, the pharmaceutical company that developed the COVID-19 drug, known as Ensitrelvir have announced that they have received emergency regulatory approval. It is the first domestically created oral COVID-19 drug for mild symptoms. Approximately a million doses will be sold to the government.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Webinars

Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars